Delivery Order SPE2DB20D3101-SPE2DB25FRRL1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $3,274.38. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a continuation of the company's pharmaceutical supply relationship with DLA. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $4,403.57 to AmerisourceBergen Drug Corp for supply of Januvia 50 mg tablets (90-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate headquarters location in...
- The Defense Logistics Agency has awarded a delivery order valued at $1,733.32 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90 count) under a firm fixed price contract. This non-set-aside award, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under contract 4568026129. This firm fixed-price delivery order, awarded on April 24, 2025, with a completion date of April 25, 2025, represents a pediatric or routine pharmaceutical supply fulfillment. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $6,126.54. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- The Defense Logistics Agency awarded a $2,187.36 delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor agreement serves as a...
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count package) valued at $1,109.94 under a firm fixed-price contract. This delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order valued at $2,728.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract type. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRL1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Januvia 50 mg tablets (90-count) under a firm fixed-price contract valued at $1,157.76, with an ultimate completion date of July 31, 2025. This non-set-aside award was issued on July 30, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order reflects the company's established role as a competitively awarded federal contractor with demonstrated capability to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/30/25 |